Nathan Lewis
GRA Eminent Scholar and Professor, Center for Molecular Medicine, Complex Carbohydrate Research Center, and Department of Biochemistry and Molecular Biology
University of Georgia 

Prof. Lewis is a GRA Eminent Scholar and Professor at the Center for Molecular Medicine, Complex Carbohydrate Research Center, and Department of Biochemistry and Molecular Biology at the University of Georgia, along with being an Adjunct Professor of Pedia trics at the University of California, San Diego. He is an expert in biotechnology and computational biology, with extensive experience in the analysis and design of cell factories and biologics. With experience in genomics and systems biology, he helped lead the public efforts to sequence the genomes of the Chinese hamster and diverse CHO cell lines. He subsequently served as the Scientific Coordinator for the CHO cell engineering program at the Novo Nordisk Foundation Center for Biosustainability and the National Biologics Facility at the Technical University of Denmark, wherein his team led the development of complex systems biology models and AI to study and engineer metabolism, protein secretion, and glycosylation in mammalian cells, and to engineer de sired traits into mammalian production hosts. He has served on advisory boards in the biotechnology and biopharma space, and is co – founder of two biopharma companies, NeuImmune, Inc. and Augment Biologics, both of which focus on the design and development of candidate glycoprotein therapeutics.